PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC
Recruiting · NCT07645222 · Registry updated 2026-07-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2026-07-06 | NCT07645222 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hansoh BioMedical R&D Company | 37 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ethics Committee of Sun Yat-sen University Cancer Center | Guangzhou | China | 2 |